A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Weight loss drugs like Ozempic and Wegovy have dominated the diet discussion for the past few years. But this trend leaves many people wondering: What role does weight-loss surgery play in an ...
There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback